UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                  SCHEDULE 13G

                   Under the Securities Exchange Act of 1934
                               (Amendment No. 1 )*

                            Meris Laboratories Inc.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                   589848100
                                 (CUSIP Number)

*The  remainder  of this  cover  shall be filled  out for a  reporting  person's
initial filing on this form with respect to the subject class of securities, and
for any  subsquenent  amendment  containing  information  which  would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).

1.  NAME OF REPORTING PERSON
     S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
        The Fairmont Fund

2.  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                  (a)
                                                                       (b)

3.  SEC USE ONLY

4.  CITIZENSHIP OR PLACE OF ORGANIZATION
        Kentucky


NUMBER OF               5.  SOLE VOTING POWER                          0
SHARES
BENEFICIALLY            6.  SHARED VOTING POWER                        0
OWNED BY
EACH                    7.  SOLE DISPOSITIVE POWER                     0
0REPORTING PERSON
WITH                    8. SHARED DISPOSITIVE POWER                    0

9.    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        None

10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
        N/A

11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        None

12.   TYPE OF REPORTING PERSON*
        IV



Cusip No.589848100                      13G                 Page 2 of 3 Pages

Schedule 13G Additional Information

Item #
1. (a)  Name of Issuer:
          Meris Laboratories Inc.

   (b)  Address of Issuer's Principal Executive Offices:
          2890 Zanker Road
          San Jose, CA  95134

2. (a)  Name of Person Filing:
          The Fairmont Fund

   (b)  Address of Principal Business Office for Each of the Above:
          1346 South Third Street
          Louisville, KY  40208

   (c)  Citizenship:
          A Kentucky Business Trust

   (d)  Title of  Class of  Securities:
          Common Stock

   (e)  CUSIP Number:
          589848100

3. This statement is filed pursuant to Rule 13d-1(b), or 13d-2(b).  The person
   filing is a:
   (a) [ ] Broker or Dealer registered under Section 15 of the Act
   (b) [ ] Bank as defined in section 3(a)(6) of the Act
   (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act
   (d) [x] Investment Company registered under section 8 of the Investment 
           Company Act
   (e) [ ] Investment Adviser registered under section 203 of the Investment 
           Advisers Act of 1940
   (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provsions
           of the Employee Retirement Income Security Act of 1974 or Endowment 
           Fund
   (g) [ ] Parent Holding Company, in accordance with 240.13d-1(b)(ii)(G) (Note:
           See Item 7)
           The Sachs  Company is an  investment  adviser  registered  under
           Section 203 of the  Investment  Advisers  Act of 1940  reporting
           under Rule 13d-1(b) (ii) (G).
   (h) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(H)

4. Ownership:
   (a) Amount Beneficially Owned:                                          0
   (b) Percent of Class:                                                   0%
   (c) Number of shares as to which such person has:
         (i) sole power to vote or to direct the vote                      0 
        (ii) shared power to vote or to direct the vote                 None  
       (iii) sole power to dispose or to direct the disposition of         0 
        (iv) shared power to dispose or to direct the disposition of    None

5. Ownership of Five Percent or Less of a Class:
        If this statement is being filed to report the fact that as of the date
        hereof the reporting person has ceased to be the beneficial owner of
        more than five percent of the class of securities, check the 
        following [ X ].








CUSIP NO.589848100                 13G                      Page 3 of 3 Pages

Schedule 13G Additional Information  (continued)

Item #
6. Ownership of More than Five Percent on Behalf of Another Person:
       N/A

7. Identification and Classification of the Subsidiary Which Acquired the 
   Security Being Reported on by the Parent Holding Company:
       N/A

8. Identification and Classification of Members of the Group:
       N/A

9. Notice of Dissolution of  Group:
       N/A

10. Certification:

       By signing below, the undersigned certifies that, to the best of its
       knowledge and belief, the securities referred to above were acquired in
       the ordinary course of business and were not acquired for the purpose of
       and do not have the effect of changing or influencing the control of the
       issuer of such securities and were not acquired in connection with or as
       a participant in any transaction having such purpose or effect.

       After reasonable inquiry and to the best of my knowledge and belief, I 
       certify that the information set forth in this statement is true, 
       complete and correct.

Dated:  February 12, 1998
        -----------------

    The Fairmont Fund
by: /s/ Louis T. Young
    Louis T. Young, Treasurer